A replicable CD271+ mesenchymal stromal cell density score: bringing the dysfunctional myelodysplastic syndrome niche to the diagnostic laboratory

Leuk Lymphoma. 2017 Jul;58(7):1730-1732. doi: 10.1080/10428194.2016.1251590. Epub 2016 Nov 3.

Authors

Eric Gars¹, Sherif M Yousry², Daniel Babu³, Jason H Kurzer¹, Tracy I George³, Dita Gratzinger¹

Affiliations

¹ a Department of Pathology , Stanford University School of Medicine , Stanford , CA , USA.
² b Department of Clinical Pathology, Faculty of Medicine , Kasr El-Ainy Hospital, Cairo University , Cairo , Egypt.
³ c Department of Pathology , University of New Mexico, University of New Mexico , Albuquerque , NM , USA.

PMID: 27808583
DOI: 10.1080/10428194.2016.1251590

No abstract available

Publication types

Letter

MeSH terms

Adapalene / metabolism*
Biomarkers
Bone Marrow / pathology
Cell Count
Cellular Microenvironment
Humans
Immunohistochemistry
Mesenchymal Stem Cells / metabolism*
Mesenchymal Stem Cells / pathology*
Myelodysplastic Syndromes / diagnosis*
Myelodysplastic Syndromes / metabolism*
Myelodysplastic Syndromes / pathology
Prognosis

Substances

Biomarkers
Adapalene